NovoCure Limited (NVCR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.61 |
| Open | 14.50 |
| Bid | 14.63 x 600 |
| Ask | 14.68 x 300 |
| Day's range | 14.17 - 14.84 |
| 52-week range | 10.87 - 24.74 |
| Volume | |
| Avg. volume | 1,024,440 |
| Market cap | 1.586B |
| Beta (5Y monthly) | 0.70 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.58 |
| Earnings date | 30 Oct 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.67 |
Business WireNovocure to Report Third Quarter 2024 Financial Results
ROOT, Switzerland, October 01, 2024--Novocure will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, before the U.S. financial markets open.
Business WireNovocure to Present Real-World Data at ESMO 2024 Demonstrating Improved Survival Outcomes for Newly Diagnosed Glioblastoma Patients with Increased Use of Tumor Treating Fields (TTFields) Therapy
ROOT, Switzerland, September 09, 2024--Novocure to Present Real-World Data at ESMO 2024
Business WireNovocure Announces Planned CEO Transition
ROOT, Switzerland, September 03, 2024--Novocure Announces Planned CEO Transition
© 2024 Yahoo. All rights reserved.